Drug Information

Drug General Information
Drug ID
D0L1OT
Former ID
DNCL003174
Drug Name
TroVax
Synonyms
TroVax (TN)
Drug Type
Vaccine
Indication Hormone refractory prostate cancer [ICD9: 140-229, 185; ICD10:C61] Phase 3 [521911]
Company
Oxford BioMedica
Target and Pathway
Target(s) 5T4 ONCOFETAL antigen Target Info [531184]
References
Ref 521911ClinicalTrials.gov (NCT00397345) TroVax Renal Immunotherapy Survival Trial. U.S. National Institutes of Health.
Ref 531184Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study. Clin Cancer Res. 2010 Nov 15;16(22):5539-47.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.